Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare Biotechnology

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Scotty is one of, “THE LOSERS”!

<< Previous

Bullboard Posts

Next >>

Comment by CyberSecurityon Mar 10, 2021 9:17pm

154 Views

Post# 32769419

RE:Scotty is one of, “THE LOSERS”!

Confirmed. Same IP. Reported.

ETalien wrote: He keeps repeating that he is going to be out on Friday, well let me tell you that this con does not have any shares. Now, like I said, they, "THE LOSERS", are saying they are going to sell on Friday! Oh really? LOSERS!!!

Good luck to ya and don't let the door hit you on the way out... oh wait a minute, you are not in!
...too funny!

<< Previous

Bullboard Posts

Next >>

Eminent acquires promising Nevada gold project